Endocrine News Podcast

We look at Vosoritide, a promising, potential treatment for children with genetic short stature who do not have chondrodysplasia. Host Aaron Lohr talks with Andrew Dauber, MD, division chief of endocrinology at Children’s National Hospital. Dr. Dauber and colleagues presented about Vosoritide at ENDO 2022. Their abstract is titled, “A Prospective Clinical Trial of Vosoritide in Selected Genetic Ca...

Endocrine-disrupting chemicals are pretty much everywhere, and all of us have some level of exposure. Today we will talk about research presented at ENDO 2022 on a group of EDCs called parabens. The title of that abstract is “Parabens Promote Pro-Tumorigenic Effects in Luminal Breast Cancer Cell Lines With Diverse Genetic Ancestry.” Host Aaron Lohr talks with one of the authors of that study, Lind...

In this episode, we talk about an exciting experimental treatment for patients with type 1 diabetes called islet cell transplantation. Host Aaron Lohr talks with David Baidal, MD, assistant professor of medicine at the University of Miami Miller School of Medicine. This episode is made possible through an unrestricted, educational grant from Vertex Pharmaceuticals. Show notes are available at http...

We know how helpful continuous glucose monitors are for individuals with diabetes, but might they be of benefit to individuals with prediabetes? Today host Aaron Lohr will talk with Hisham Farhan, MD, an endocrinology fellow at the University of Maryland Medical Center. Dr. Farhan and colleagues made an oral presentation at ENDO 2022 titled, “Impact of Continuous Glucose Monitoring (CGM) on Lifest...

Fructose is sweeter than glucose and is often added to processed foods as a sweetener, commonly in the form of high-fructose corn syrup. Some studies suggest that fructose consumption may be associated with nonalcoholic fatty liver disease, and some new research, recently presented at ENDO, addresses this issue. Host Aaron Lohr talks with one of the authors of this research, Theodore Friedman, MD,...

Today we shine a spotlight on a fascinating area of focus within endocrinology that maybe you haven't heard much about: oncoendocrinology. What is it, and how are health providers working together to care for patients who have endocrine conditions and cancer? Host Aaron Lohr talks with Afreen I. Shariff, MD, an endocrinologist at Duke University School of Medicine with expertise in endocrine disea...

We know that exercise is good for us, but for athletes who run, how might that level of running impact their bones? Host Aaron Lohr talks about new research on this topic presented at ENDO 2022 with one of the study’s presenters, Melanie Schorr Haines, MD, assistant professor of medicine at Massachusetts General Hospital. Dr. Haines and colleagues’ presentation at ENDO 2022 is titled, “Male Runner...

In this episode, Aaron talks with Jennifer Dias from the Icahn School of Medicine at Mount Sinai about gestational diabetes, its association with postpartum depressive symptoms (“maternity blues”), and a predictor that may help prevent gestational diabetes from developing into type 2 diabetes. Ms. Dias, an MD candidate, presented research at ENDO 2022 titled, “Predictors of Postpartum Depressive S...

In this episode, we talk about a potential marker to help identify youth with type 1 diabetes, islet autoimmunity, and insulin deficiency. This new research was presented at ENDO 2022, and the abstract is titled, “Elevated Serum IgA at Onset of Type 1 Diabetes in Children.” Host Aaron Lohr speaks with one of the authors, Amruta Thakkar, MD, of Texas Children’s Hospital and the Baylor College of Me...

We all know how important diet and exercise are to weight loss and maintenance, but what about anti-obesity medications? How efficient are they? Host Aaron Lohr speaks with Michael Weintraub, MD, clinical fellow in endocrinology, diabetes, and metabolism at New York-Presbyterian Hospital/Weill Cornell Medical Center. Dr. Weintraub and colleagues presented in an oral session during the Endocrine So...

Host Aaron Lohr returns to in-person interviews, starting with the Endocrine Society's 2022 annual meeting in Atlanta. Here he talks about the effects of SARS-COV2 on ovulation with someone we have been talking with since the beginning: Jerilynn C. Prior, MD, professor of endocrinology and metabolism at the University of British Columbia in Vancouver. Dr. Prior and colleagues presented in an oral...

Host Aaron Lohr talks about incretins and type 2 diabetes management with Zhenqi Liu, MD, chief of the Division of Endocrinology and Metabolism at the University of Virginia School of Medicine. This episode is certified for up to 0.5 American Medical Association Physician's Recognition Award (AMA PRA) Category 1 credits and American Board of Internal Medicine Maintenance of Certification (ABIM MOC...

In recent years, much attention has been paid to the amount of Bisphenol A, or BPA, an endocrine-disrupting chemical, found in plastic products. But are the standards we have in place enough? Host Aaron Lohr talks with Heather Patisaul, PhD, of North Carolina State University. An Endocrine Society member, Dr. Patisaul is an expert on BPA whose research contributed to findings from a coalition that...

For our 50th episode since launching in 2018, host Aaron Lohr takes a look at drone and robotic technology being used for medicine delivery and patient education. He speaks with Derek O’Keeffe, MD, PhD, of the National University of Ireland, Galway, who has been at the forefront of this development in patient care. Dr. O’Keeffe will present on Tuesday, November 9, at the Endocrine Society's upcomi...

Host Aaron Lohr talks about cardiovascular disease and type 2 diabetes with Jonathan Purnell, MD, from Oregon Health & Science University. Dr. Purnell chaired the Endocrine Society's recent educational series, “Current and Future State of Cardiovascular Disease in Type 2 Diabetes,” which is available through December 2021. For more information, including helpful links and other episodes, visit our...

We explore type 1 diabetes, everything from diagnosis to treatment strategies, hypoglycemia, technology, and teleheath. Host Aaron Lohr talks with Irl Hirsch, MD, from the University of Washington, and Davida Kruger, NP, from the Henry Ford Health System. They co-chair the Endocrine Society's 8th Annual Endocrine Fellows Type 1 Diabetes Care and Management Program. For more information, including...

Host Aaron Lohr talks about vitamin D insufficiency and COVID-19 with Laurel Mohrmann, MD, and Sweta Chekuri, MD, both from Montefiore Medical Center in the Bronx. Drs. Mohrmann and Chekuri participated on a team that presented in March on vitamin D insufficiency at ENDO 2021. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Host Aaron Lohr talks about thyroiditis and COVID-19 with Ilaria Muller, MD, PhD, from the University of Milan. Dr. Muller presented her research in March at ENDO 2021: “Early Follow-up of Atypical Thyroiditis Induced by SARS-CoV-2.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

A new study in The Journal of Clinical Endocrinology & Metabolism shows the relationship between abnormal sodium levels and greater risk of respiratory failure and death in patients with COVID-19. Host Aaron Lohr speaks with two of the authors, Ploutarchos Tzoulis, MD, PhD, from University College London Medical School and Julian Waung, PhD, from the Whittington Health NHS Trust in London. For mor...

The pandemic has changed the world of medical and science conferences, including the Endocrine Society's annual meeting, ENDO 2021, which will be an all-virtual event. Host Aaron Lohr talks with Felix Beuschlein, a professor at University Hospital Zurich and chair of the Society's annual meeting steering committee, about what to expect. ENDO 2021 will be held on March 20-23. For more information,...

Today we celebrate 100 years since the discovery of insulin. We talk with Elizabeth A. Stephens, MD, an endocrinologist with the Providence Medical Group in Portland, Ore., about the importance of this landmark discovery, how it shaped our understanding and treatment of diabetes, and how it sets the stage for the exciting breakthroughs of tomorrow. For more information, including helpful links and...

We look at sugars and appetite with Kathleen Page, MD, associate professor of medicine at the University of Southern California Keck School of Medicine. Dr. Page is the corresponding author of a new article published in The Journal of Clinical Endocrinology and Metabolism, “Appetite-Regulating Hormones Are Reduced After Oral Sucrose vs Glucose: Influence of Obesity, Insulin Resistance, and Sex.” F...

Host Aaron Lohr talks about time in range, hypoglycemia, and continuous glucose monitoring with Steven Edelman, MD, and Jeremy Pettus, MD, from the University of California, San Diego, and Rayhan Lal, MD, of Stanford University. Once you finish listening, take a survey, and you will receive a fashionable pancreas pin. The survey and all other links can be found at https://www.endocrine.org/podcast...

Hear host Aaron Lohr's talk with Donna Ryan from Pennington Biomedical about the latest developments in obesity treatment. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Host Aaron Lohr talks about hypoglycemia with Elizabeth Seaquist, MD, from the University of Minnesota, and Cecilia Low Wang, MD, from the University of Colorado Hospital. Drs. Seaquist and Low Wang are the faculty of the ENDO Online 2020 session titled “Severe Hypoglycemia: The Frequently Forgotten Threat.” Once you have listened to the episode, let us know what you think about it by taking a sur...